NCT05871476

Brief Summary

Carbapenem resistant Enterobacteriaceae (CRE) colonization of patients discharged from hospitals is a source of transmission to the community. In a cluster randomized controlled trial the effect of a bundle of interventions will be assessed on CRE transmission from CRE+ index patient discharged from hospital to HouseHold (HH) members. The districts in two provinces will be randomized to intervention or control. An information, communication, education and hygiene intervention, developed in collaboration with local health authorities, will aim to improve hygiene and decrease antibiotic (AB) use. The effect will be evaluated on CRE transmission between HH members, livestock and environment through consecutive CRE screening using fecal and hospital effluent samples cultured on carbapenem selective media. Knowledge, Attitudes, Practice surveys with smartphones will assess health seeking, AB use and hygiene adherence, hence detecting the effect of interventions. If transmission of CRE +/- Colistin Resistant Enterobacteriaceae (CoRE, common among livestocks) is detected the source will be investigated including livestock and food, targeted information will be given and evaluated. In hospitals the effect of cohort care will be assessed on CRE acquisition, hospital acquired infection, treatment outcome, costeffectiveness and contamination in sewage water. Mechanisms of resistance, relatedness of CRE isolates in different One Health departments, and rate of CRE transmission from humans to animals and vice versa, will be assessed through Whole Genome Sequencing (WGS).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for not_applicable

Timeline
2mo left

Started Jul 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jul 2022Jun 2026

Study Start

First participant enrolled

July 1, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 4, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 23, 2023

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

June 24, 2025

Status Verified

June 1, 2025

Enrollment Period

3.5 years

First QC Date

May 4, 2023

Last Update Submit

June 18, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change the prevalence of CRE colonisation

    The intervention at hospital will lead to the reduction of CRE colonisation, hospital acquire infection, treatment duration and costs.

    12 months from the starting of recruitment patients

  • Cheng th prevalence of CRE transmission in the household

    The Household Education Communication Hygiene Intervention expected to reduce the transmission of CRE from index patient to household member.

    12 months from the starting of recruitment community participants

  • Change the awareness regarding AMR of local people

    The understanding on AMR, particularly of CRE, proper use of antibiotic for both humans and animals, will be improved. This will be measured through the quantitative questionnaires.

    18 months from the starting of recruitment community participants

  • Assessment the effectiveness of the hospital wastewater treatment on reducing CRE from hospital to community

    The presence of CRE in hospital wastewater before and after treatment will be compared to evaluate the effectiveness of the treatment system on preventing the spreading of AMR to the community.

    24 months from the starting of the project

  • Investigate the genetic relatedness of CRE isolates from hospital, household, animals, wastewater

    The CRE isolated from rectal swab of patient admitted to hospital, household members, animals and wastewater will be subjected to Whole Genome Sequencing using Oxford MinION Nanopore/Illumina Miseq sequencing and bioinformatics analysis to investigate the mechanisms of resistance in different One-Health compartments.

    24 months from the starting of the project

Study Arms (2)

Intervention district

ACTIVE COMPARATOR

An information, communication, education and hygiene intervention, developed in collaboration with local health authorities, will aim to improve hygiene and decrease antibiotic use.

Behavioral: , Household Education Communication Hygiene Intervention, Livestock Antibiotic Intervention

cohort care at the hospital

ACTIVE COMPARATOR

A laminated note (yellow for "suspicious CRE carrier": green for (CRE-) patients and red for (CRE+) patients) should be put on the front of the patients' bed.

Behavioral: Hospital Cohort Care Intervention at the hospital

Interventions

There will be 3 different cohort groups for the patients: 1) Unknown CRE colonisation status with increased barrier precautions (all patients until screening results arrive will belong to this group unless there are available screening results from referral hospital), 2) CREpos, and 3) CREneg. CREpos patients (2) will be treated in one area of the ICUs by specially assigned nurses/personnel.

cohort care at the hospital

The intervention will focus on two main measurable outcomes: 1) Decrease feco-oral-animal transmission route to prevent in-HH and community spread of CRE +/- CoRE. 2) Decrease unindicated community use of ABs for humans and animals. This WP focuses on a one health intervention in collaboration with local health authorities, developing and implementing an HH Education Communication Hygiene Intervention (HECHI) to improve HH hygiene and health management and reduce the risk of transmission between humans and animals, a Provider Engagement Intervention (PEI) to improve case management of common infection and decrease unindicated AB, and and a Livestock AB Intervention (LAI) to reduce the use of AB in livestock through improved biosecurity conditions and animal husbandry.

Intervention district

Eligibility Criteria

AgeUp to 24 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • All patients under 2 years old at the selected hospital are highly appreciated to join the study.

You may not qualify if:

  • Patients not from the selected hospital and individuals outside the selected province

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thai Binh Pediatric Hospital

Thái Bình, Thai Binh, 06122, Vietnam

RECRUITING

Study Officials

  • Mattias Larsson, MD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR
  • Thirumalaisamy Velavan, PhD

    University of Tübingen, Germany

    PRINCIPAL INVESTIGATOR
  • Håkan Hanberger

    Linkoeping University

    STUDY DIRECTOR
  • Flavie Goutard, PhD

    CIRAD, France

    PRINCIPAL INVESTIGATOR
  • Yaovi Mahuton Gildas Hounmanou, PhD

    University of Copenhagen

    PRINCIPAL INVESTIGATOR
  • Minh-Dien Tran

    Vietnam National Children's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Phuc Pham-Duc, MD, PhD

CONTACT

Viet-Linh Nguyen, BVetMed, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Director of Center for Public Health and Ecosystem Research

Study Record Dates

First Submitted

May 4, 2023

First Posted

May 23, 2023

Study Start

July 1, 2022

Primary Completion

December 31, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

June 24, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations